Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease

BMC Neuroscience

Volumn 9, Issue , 2008, Pages

  Van Dellen, Anton ^a   Cordery, Patricia M ^a   Spires, Tara L ^a,b   Blakemore, Colin ^a   Hannan, Anthony J ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; HD PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN WEIGHT; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; ENVIRONMENTAL ENRICHMENT; EXERCISE; EXPLORATORY BEHAVIOR; FEMALE; HABITUATION; HUNTINGTON CHOREA; LOCOMOTION; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PHYSICAL ACTIVITY; PROTEIN AGGREGATION; ROTAROD TEST; RUNNING; SENSORY STIMULATION; AGING; ANIMAL; ATROPHY; BRAIN; CELL INCLUSION; DISEASE COURSE; DISEASE MODEL; ENVIRONMENTAL PLANNING; GENETICS; KINESIOTHERAPY; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

AGING; ANIMALS; ATROPHY; BRAIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENVIRONMENT DESIGN; EXERCISE THERAPY; EXPLORATORY BEHAVIOR; FEMALE; HUNTINGTON DISEASE; INCLUSION BODIES; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHYSICAL CONDITIONING, ANIMAL;

EID: 42549092746     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-9-34     Document Type: Article

References (59)

1. Bates G Harper P Jones L Huntington's Disease, Oxford Monographs on Medical Genetics 45 Oxford University Press, Oxford Third 2002
2. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is unstable on Huntington's disease chromosomes Cell 1993 72:971-983 10.1016/0092-8674(93)90585-E 8458085
3. Mangiarini L Sathasivam K Seller M Cozens B Harper A Hetherington C Lawton M Trottier Y Lehrach H Davies SW Bates GP Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice Cell 1996 87:493-506 10.1016/ S0092-8674(00)81369-0 8898202
4. Cha JH Frey AS Alsdorf SA Kerner JA Kosinski CM Mangiarini L Penney JB Davies SW Bates GP Young AB Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease Philos Trans R Soc Lond B Biol Sci 1999 354:981-989 1692608 10434296 10.1098/rstb.1999.0449
5. Hansson O Petersen A Leist M Nicotera P Castilho RF Brundin P Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal exctitotoxicity Proc Natl Acad Sci USA 1999 96:8727-8732 17584 10411943 10.1073/pnas.96.15.8727
6. Van Dellen A Blakemore C Deacon R York D Hannan AJ Delaying the onset of Huntington's in mice Nature 2000 404:721-722 10.1038/35008142 10783874
7. Van Dellen A Welch J Dixon RM Cordery P York D Styles P Blakemore C Hannan AJ N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington's disease mice Neuroreport 2000 11:3751-3757 10.1097/00001756-200011270-00032 11117485
8. Spires TL Grote HE Varshney NK Cordery PM van Dellen A Blakemore C Hannan AJ Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism J Neurosci 2004 24:2270-2276 10.1523/JNEUROSCI.1658-03.2004 14999077
9. Spires TL Grote HE Garry S Cordery PM Van Dellen A Blakemore C Hannan AJ Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice Eur J Neurosci 2004 19:2799-2807 10.1111/j.0953-816X.2004.03374.x 15147313
10. Nithianantharajah J Hannan AJ Enriched environments, experience-dependent plasticity and disorders of the nervous system Nature Rev Neurosci 2006 7(9):697-709 10.1038/nrn1970 16924259
11. Hockly E Cordery PM Woodman B Mahal A Van Dellen A Blakemore C Lewis CM Hannan AJ Bates GP Environmental enrichment slows disease progression in R6/2 Huntington's disease mice Ann Neurol 2002 51:235-242 10.1002/ ana.10094 11835380
12. Turmaine M Raza A Mahal A Mangiarini L Bates GP Davies SW Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease Proc Natl Acad Sci USA 2000 97:8093-8097 16675 10869421 10.1073/ pnas.110078997
13. van Dellen A Deacon R York D Blakemore C Hannan AJ Anterior cingulate cortical transplantation in transgenic Huntington's disease mice Brain Res Bull 2001 56:313-318 10.1016/S0361-9230(01)00655-4 11719266
14. Pang TY Stam NC Nithianantharajah J Howard ML Hannan AJ Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice Neuroscience 2006 141:569-584 10.1016/ j.neuroscience.2006.04.013 16716524
15. DiFiglia M Sapp E Chase KO Davies SW Bates GP Vonsattel JP Aronin N Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 1997 277:1990-1993 10.1126/ science.277.5334.1990 9302293
16. Davies SW Turmaine M Cozens BA DiFiglia M Sharp AH Ross CA Scherzinger E Wanker EE Mangiarini L Bates GP Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 1997 90:537-548 10.1016/S0092-8674(00)80513-9 9267033
17. Schilling G Savonenko AV Coonfield ML Morton JL Vorovich E Gale A Neslon C Chan N Eaton M Fromholt D Ross CA Borchelt DR Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice Exp Neurol 2004 187:137-149 10.1016/ j.expneurol.2004.01.003 15081595
18. Nithianantharajah AJ Barkus C Murphy M Hannan AJ Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice Neurobiology of Disease 2008 29:490-504 18165017 10.1016/j.nbd.2007.11.006
19. Cha JH Kosinski CM Kerner JA Alsdorf SA Mangiarini L Davies SW Penney JB Bates GP Young AB Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene Proc Natl Acad Sci USA 1998 95:6480-6485 27817 9600992 10.1073/ pnas.95.11.6480
20. Luthi-Carter R Strand A Peters NL Solano SM Hollingsworth ZR Menon AS Frey AS Spektor BS Penney EB Schilling G Ross CA Borchelt DR Tapscott SJ Young AB Cha JH Olson JM Decreased expression of striatal signalling genes in a mouse model of Huntington's disease Hum Mol Genet 2000 9:1259-1271 10.1093/hmg/9.9.1259 10814708
21. Kuhn A Goldstein DR Hodges A Strand AD Sengstag T Kooperberg C Becanovic K Pouladi MA Sathasivam K Cha JH Hannan AJ Hayden MR Leavitt BR Dunnett SB Ferrante RJ Albin R Shelbourne P Delorenzi M Augood SJ Faull RL Olson JM Bates GP Jones L Luthi-Carter R Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage Hum Mol Genet 2007 16:1845-61 10.1093/hmg/ddm133 17519223
22. Glass M Dragunow M Faull RL The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease Neuroscience 2000 97:505-519 10.1016/ S0306-4522(00)00008-7 10828533
23. Glass M van Dellen A Blakemore C Hannan AJ Faull RL Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors Neuroscience 2004 123:207-212 10.1016/S0306-4522(03)00595-5 14667455
24. Ferrer I Goutan E Marin C Rey MJ Ribalta T Brain-derived neurotrophic factor in Huntington disease Brain Res 2000 866:257-261 10.1016/ S0006-8993(00)02237-X 10825501
25. Zuccato C Ciammola A Rigamonti D Leavitt BR Goffredo D Conti L MacDonald ME Friedlander RM Silani V Hayden MR Timmusk T Sipione S Cattaneo E Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease Scienc 2001 293:5529-493 498 11408619
26. Zuccato C Tartari M Crotti A Goffredo D Valenza M Conti L Cataudella T Leavitt BR Hayden MR Timmusk T Rigamonti D Cattaneo E Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes Nat Genet 2003 35:76-83 10.1038/ng1219 12881722
27. Canals JM Pineda JR Torres-Peraza JF Bosch M Martin-Ibanez R Munoz MT Mengod G Ernfors P Alberch J Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease J Neurosci 2004 24:7727-7739 10.1523/JNEUROSCI.1197-04.2004 15342740
28. Cepeda C Starling AJ Wu N Nguyen OK Uzgil B Soda T Andre VM Ariano MA Levine MS Increased GABAergic function in mouse models of Huntington's disease: Reversal by BDNF J Neurosci Res 2004 78:855-867 10.1002/ jnr.20344 15505789
29. Gauthier LR Charrin BC Borrell-Pages M Dompierre JP Rangone H Cordelieres FP De Mey J MacDonald ME Lessmann V Humbert S Saudou F Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules Cell 2004 118:127-138 10.1016/j.cell.2004.06.018 15242649
30. Cepeda C Wu N Andre VM Cummings DM Levine MS The corticostriatal pathway in Huntington's disease Prog Neurobiol 2007 81:253-271 1913635 17169479 10.1016/j.pneurobio.2006.11.001
31. Milnerwood AJ Cummings DM Dallerac GM Brown JY Vatsavayai SC Hirst MC Rezaie P Murphy KP Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease Hum Mol Genet 2006 15:1690-703 10.1093/hmg/ddl092 16600988
32. Murphy KP Carter RJ Lione LA Mangiarini L Mahal A Bates GP Dunnett SB Morton AJ Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation J Neurosci 2000 20:5115-5123 10864968
33. Hodgson JG Agopyan N Gutekunst CA Leavitt BR LePiane F Singaraja R Smith DJ Bissada N McCutcheon K Nasir J Jamot L Li XJ Stevens ME Rosemond E Roder JC Phillips AG Rubin EM Hersch SM Hayden MR A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration Neuron 1999 23:181-192 10.1016/S0896-6273(00)80764-3 10402204
34. Usdin MT Shelbourne PF Myers RM Madison DV Impaired synaptic plasticity in mice carrying the Huntington's disease mutation Hum Mol Genet 1999 8:839-846 10.1093/hmg/8.5.839 10196373
35. Cummings DM Milnerwood AJ Dallerac GM Waights V Brown JY Vatsavayai SC Hirst MC Murphy KP Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease Hum Mol Genet 2006 15:2856-68 10.1093/hmg/ddl224 16905556
36. Cybulska-Klosowicz A Mazarakis NK van Dellen A Blakemore C Hannan AJ Kossut M Impaired learning-dependent cortical plasticity in Huntington's disease transgenic mice Neurobiol Dis 2004 17:427-434 10.1016/ j.nbd.2004.08.009 15571978
37. Mazarakis NK Cybulska-Klosowicz A Grote H Pang T Van Dellen A Kossut M Blakemore C Hannan AJ Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice J Neurosci 2005 25:3059-3060 10.1523/ JNEUROSCI.4320-04.2005 15788762
38. Foster TC Gagne J Massicotte G Mechanism of altered synaptic strength due to experience: Relation to long-term potentiation Brain Res 1996 736:243-250 10.1016/0006-8993(96)00707-X 8930330
39. van Praag H Christie BR Sejnowski TJ Gage FH Running enhances neurogenesis, learning, and long-term potentiation in mice Proc Natl Acad Sci USA 1999 96:13427-13431 23964 10557337 10.1073/pnas.96.23.13427
40. Lazic SE Grote H Armstrong RJ Blakemore C Hannan AJ van Dellen A Barker RA Decreased hippocampal cell proliferation in R6/1 Huntington's mice Neuroreport 2004 15:811-813 10.1097/00001756-200404090-00014 15073520
41. Grote HE Bull ND Howard ML van Dellen A Blakemore C Bartlett PF Hannan AJ Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine Eur J Neurosci 2005 22(8):2081-2008 10.1111/j.1460-9568.2005.04365.x 16262645
42. Gil JM Leist M Popovic N Brundin P Petersen A Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice BMC Neurosci 2004 5:17 434499 15134587 10.1186/1471-2202-5-17
43. Gil JM Mohapel P Araujo IM Popovic N Li JY Brundin P Petersen A Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice Neurobiol Dis 2005 20:744-751 10.1016/j.nbd.2005.05.006 15951191
44. Lazic SE Grote HE Blakemore C Hannan AJ van Dellen A Phillips W Barker RA Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: Effects of environmental enrichment Eur J Neurosci 2006 23:1829-1838 10.1111/j.1460-9568.2006.04715.x 16623840
45. Van Praag H Kempermann G Gage FH Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus Nature Neurosci 1999 2:266-267 10.1038/6368 10195220
46. Moskowitz CB Marder K Palliative care for people with late-stage Huntington's disease Neurol Clin 2001 19:849-865 10.1016/ S0733-8619(05)70050-5 11854103
47. Sullivan FR Bird ED Alpay M Cha JH Remotivation therapy and Huntington's disease J Neurosci Nurs 2001 33:136-142 11413658
48. Wexler NS Lorimer J Porter J Gomez F Moskowitz C Shackell E Marder K Penchaszadeh G Roberts SA Gayan J Brocklebank D Cherny SS Cardon LR Gray J Dlouhy SR Wiktorski S Hodes ME Conneally PM Penney JB Gusella J Cha JH Irizarry M Rosas D Hersch S Hollingsworth Z MacDonald M Young AB Andresen JM Housman DE De Young MM Bonilla E Stillings T Negrette A Snodgrass SR Martinez-Jaurrieta MD Ramos-Arroyo MA Bickham J Ramos JS Marshall F Shoulson I Rey GJ Feigin A Arnheim N Acevedo-Cruz A Acosta L Alvir J Fischbeck K Thompson LM Young A Dure L O'Brien CJ Paulsen J Brickman A Krch D Peery S Hogarth P Higgins DS Jr Landwehrmeyer B U.S.-Venezuela Collaborative Research Project Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset Proc Natl Acad Sci USA 2004 101:3498-3503 373491 14993615 10.1073/pnas.0308679101
49. Georgiou N Bradshaw JL Chiu E Tudor A O'Gorman L Phillips JG Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease Mov Disord 1999 14:320-325 10.1002/1531-8257(199903)14:2<320::AID-MDS1018>3.0.CO;2-Z 10091627
50. Valenzuela MJ Sachdev P Brain reserve and dementia: A systematic review Psychol Med 2006 36:441-454 10.1017/S0033291705006264 16207391
51. Arendash GW Garcia MF Costa DA Cracchiolo JR Wefes IM Potter H Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition Neuroreport 2004 15:1751-1754 10.1097/01.wnr.0000137183.68847.4e 15257141
52. Adlard PA Perreau VM Pop V Cotman CW Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease J Neurosci 2005 25:4217-4221 10.1523/JNEUROSCI.0496-05.2005 15858047
53. Jankowsky JL Melnikova T Fadale DJ Xu GM Slunt HH Gonzales V Younkin LH Younkin SG Borchelt DR Savonenko AV Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease J Neurosci 2005 25:5217-5224 10.1523/JNEUROSCI.5080-04.2005 15917461
54. Lazarov O Robinson J Tang YP Hairston IS Korade-Mirnics Z Lee VM Hersh LB Sapolsky RM Mirnics K Sisodia SS Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice Cell 2005 120:701-713 10.1016/j.cell.2005.01.015 15766532
55. Bezard E Dovero S Belin D Duconger S Jackson-Lewis V Przedborski S Piazza PV Gross CE Jaber M Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: Involvement of dopamine transporter and trophic factors J Neurosci 2003 23:10999-11007 14657156
56. Sale A Maya Vetencourt JF Medini P Cenni MC Baroncelli L De Pasquale R Maffei L Environmental enrichment in adulthood promotes amblyopia recovery through a reduction of intracortical inhibition Nat Neurosci 2007 10:679-681 10.1038/nn1899 17468749
57. Steffan JS Thompson LM Targeting aggregation in the development of therapeutics for the treatment of Huntington's disease and other polyglutamine repeat diseases Expert Opin Ther Targets 2003 7:201-13 12667098
58. Hannan AJ Novel therapeutic targets for Huntington's disease Expert Opin Ther Targets 2005 9:639-650 10.1517/14728222.9.4.639 16083335
59. Hannan AJ Blakemore C Katsnelson A Vitalis T Huber KM Bear M PLC-β1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex Nature Neurosci 2001 4:282-288 10.1038/85132 11224545